DEL ROSSO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 13.448
EU - Europa 8.842
AS - Asia 5.335
SA - Sud America 568
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 130
OC - Oceania 107
Totale 28.647
Nazione #
US - Stati Uniti d'America 13.234
RU - Federazione Russa 2.670
PL - Polonia 1.629
SG - Singapore 1.604
IT - Italia 1.494
CN - Cina 1.222
HK - Hong Kong 841
SE - Svezia 746
IE - Irlanda 623
VN - Vietnam 497
KR - Corea 442
BR - Brasile 423
DE - Germania 347
FI - Finlandia 300
UA - Ucraina 297
GB - Regno Unito 233
FR - Francia 186
IN - India 155
CA - Canada 128
NL - Olanda 124
JO - Giordania 123
BD - Bangladesh 106
AU - Australia 105
JP - Giappone 79
ID - Indonesia 59
AR - Argentina 47
TR - Turchia 46
CI - Costa d'Avorio 37
CH - Svizzera 35
IQ - Iraq 35
BE - Belgio 34
ES - Italia 32
MX - Messico 32
AT - Austria 28
CO - Colombia 24
ZA - Sudafrica 22
EC - Ecuador 21
VE - Venezuela 18
UZ - Uzbekistan 16
PH - Filippine 15
SA - Arabia Saudita 15
CR - Costa Rica 14
PK - Pakistan 14
PY - Paraguay 12
SC - Seychelles 12
CL - Cile 10
KE - Kenya 9
NG - Nigeria 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
LT - Lituania 8
LV - Lettonia 8
MA - Marocco 8
PE - Perù 7
TN - Tunisia 7
EG - Egitto 6
EU - Europa 6
IL - Israele 6
MY - Malesia 6
NI - Nicaragua 6
RO - Romania 6
SN - Senegal 6
TW - Taiwan 6
AZ - Azerbaigian 5
DZ - Algeria 5
GT - Guatemala 5
NO - Norvegia 5
NP - Nepal 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
RS - Serbia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
DK - Danimarca 3
HR - Croazia 3
MD - Moldavia 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
LC - Santa Lucia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
Totale 28.416
Città #
Santa Clara 2.477
Warsaw 1.624
Ashburn 1.416
Singapore 1.153
Fairfield 969
Chandler 801
Hong Kong 702
Dublin 622
San Jose 593
Jacksonville 514
Woodbridge 474
Seoul 435
Seattle 419
Cambridge 385
Houston 375
Wilmington 329
Beijing 289
Ann Arbor 282
Milan 277
Buffalo 251
Council Bluffs 245
Los Angeles 207
Hefei 203
Florence 186
Princeton 175
The Dalles 170
Ho Chi Minh City 140
Rome 123
Helsinki 120
Lauterbourg 118
Boardman 116
Boston 115
Lawrence 113
Altamura 111
Amsterdam 108
Hanoi 101
Melbourne 100
Munich 99
New York 93
Moscow 92
Shanghai 91
Mumbai 88
Medford 85
Dallas 83
Tokyo 76
Phoenix 63
San Diego 58
Chicago 50
Jakarta 42
Kent 40
Turku 39
Abidjan 37
São Paulo 37
Columbus 35
Brussels 34
Clifton 34
Naples 34
Toronto 33
Bern 32
Dong Ket 30
London 28
Paris 28
Norwalk 27
Turin 27
Vienna 27
Bologna 25
Orem 25
Brooklyn 24
Figino 23
North Bergen 23
Redondo Beach 23
West Jordan 22
Genoa 21
Izmir 21
Barcelona 20
Da Nang 20
Haiphong 20
Yubileyny 20
Bari 19
Frankfurt am Main 19
Verona 19
Guangzhou 18
Hillsboro 18
Montreal 18
Palermo 18
Falls Church 17
Baghdad 16
Catania 15
Salerno 15
Tashkent 15
San Francisco 14
Johannesburg 13
Rio de Janeiro 13
Bengaluru 12
Denver 12
Frankfurt Am Main 12
Manchester 12
San José 12
Stockholm 12
Andover 11
Totale 18.897
Nome #
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 394
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 390
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 388
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 350
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 333
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 321
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 318
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 316
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 313
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 302
Type II CRISPR/Cas9 approach in the oncological therapy 295
Oleuropein aglycone attenuates the pro-angiogenic phenotype of senescent fibroblasts: a functional study in endothelial cells 268
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 264
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 263
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 258
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 248
Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer. 246
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 238
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 236
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 234
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 234
FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-Kinase dependent activation of poly(ADP-Ribose) polymerase 232
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 228
Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. 226
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 225
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 224
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 222
Fabrication of GM3-enriched sphingomyelin/cholesterol solid-supported lipid membranes on Au/SiO2 plasmonic substrates. 221
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 218
Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. 216
CELL SURFACE GLYCOSAMINOGLYCANS IN NORMAL END LEUKEMIC LEUKOCYTES. 213
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 212
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis 212
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 210
Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. 209
Involvement of modulation of cell coat glycosaminoglycans in guinea pig peritoneal macrophage activity 209
Intercellular glycosaminoglycans in human cancer 208
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 207
Endothelial sphingosine kinase/SPNS2 axis has a critical role in migration and vessel-like formation of human mesoangioblasts 206
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 201
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system. 200
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 198
Cell-mediated release of nanoparticles as a preferential option for future treatment of melanoma 197
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 196
Brn-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis. 196
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. 195
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 194
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 194
I SINOVIOCITI DI ARTRITE REUMATOIDE (AR) PRESENTANO IL PATTERN FIBRINOLITICO DELLE CELLULE INVASIVE. REUMATISMO, 2001 VOL 53 N°3 (SUPPL. N° 4) 193
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 193
Surface glycosaminoglycans and calcium distribution in 3T3 cells. 190
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 190
Divergent regulation of long non-coding RNAs H19 and PURPL affects cell senescence in human dermal fibroblasts. 189
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. 188
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 188
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 187
Inhibition of spontaneous growth and induced differentiation of murine erythroleukaemia cells by paraquat and atrazine. 186
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 185
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system. 185
Sulphated polysaccharides and the differentiation of the cellular slime mould Dictyostelium discoideum 185
Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. 184
Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters 184
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 183
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 183
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent-Associated Secretory Phenotype" on endothelial colony-forming cells: The role of IL8 182
ELECTROPHORETIC CHARACTERIZATION OF SURFACE HEPARAN SULPHATES IN NORMAL AND VIRUS TRANSFORMED 3T3 CELLS. 182
TGFb1 antagonistic peptides inhibit TGFb1-dependent angiogenesis 182
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. 178
Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. 178
Modulation of urokinase receptors on human synovial cells and osteoarthritic chondrocytes by diacetylrhein 178
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 177
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 176
Plasminogen activator: morphological evidence of binding, internalization and delivery to lysosomes in 3T3 mouse fibroblasts. 175
Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. 175
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 175
FGF-2 EFFECT ON POLY(ADP-RIBOSE) POLYMERASE ACTIVITY IN TRANSFORMED BOVINE ENDOTHELIAL CELLS 175
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 175
I GLICOSAMINOGLICANI NELL'ADESIONE DEI LEUCOCITI POLIMORFONUCLEATI E DELLE PIASTRINE. 174
Adhesion-dependent heparin production by platelets. 174
The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition. 173
Pulsed-Laser-Driven CO2 Reduction Reaction for the Control of the Photoluminescence Quantum Yield of Organometallic Gold Nanocomposites 171
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 169
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 169
Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts 168
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 167
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 167
FGF2 in Human Melanoma Progression: The Antithetical Functions of Different Isoforms 167
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 165
CHARACTERIZATION OF FIBRINOLYTIC PATTERN OF SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS (RA). J RHEUMATOL , 28 (SUPPLEMENT 63) 164
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 163
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice 163
Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells. 163
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 163
Anti-urokinase receptor antisense oligonucleotide (uPar-aODN) to prevent and cure long-term space exploration related retinal pathological angiogenesis 163
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. 161
Plasminogen activators and inhibitor type-1 in alveolar osteitis. 160
Parvovirus B19 (B19V) induces cellular senescence in human dermal fibroblasts: putative role in SSc-associated fibrosis. 160
Poly(ADP-ribosyl)ation, a molecular switch of transcription, shows an attractive relationship with urokinase expression 159
A Possible Role for PAI-1 Blockade in Melanoma Immunotherapy 157
Receptors for plasminogen activators, urokinase, in normal and Rous Sarcoma Virus-transformed mouse fibroblasts 156
Totale 20.975
Categoria #
all - tutte 77.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022968 0 0 46 57 47 51 36 78 60 50 254 289
2022/20232.987 302 463 143 251 263 527 377 207 325 11 67 51
2023/20241.037 37 131 156 46 71 138 40 267 13 60 46 32
2024/20257.176 265 737 437 1.100 2.169 939 89 453 288 162 300 237
2025/20268.079 926 1.070 573 617 911 327 1.028 400 562 464 224 977
2026/20271.260 279 268 713 0 0 0 0 0 0 0 0 0
Totale 28.647